Delivery Order SPE2DB24D2216-SPE2DB25FGNNB

Award Date 5/1/25
Potential Completion Date 5/2/25
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of fluticasone-salmeterol 115-21 12GM inhalation aerosol, a medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract has a ceiling value of $9,236.69 and a period of performance through June 20, 2024. It is a firm-fixed-price contract, and there was...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,475.42 contract is for the delivery of fluticasone-salmeterol 115-21 12GM, a medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of April 11, 2025 and is not set aside for any special type of business. AmerisourceBergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of fluticasone-salmeterol 45-21 12GM, a combination medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract has a firm fixed price of $4,119.94 and a completion date of October 25, 2024. It is not designated as a set-aside contract, indicating open...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,766.90 firm-fixed-price contract is for the supply of fluticasone-salmeterol 45-21 12GM, a medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of February 25, 2025 and was awarded on February 24, 2025....
This is a $5,414.15 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of fluticasone-salmeterol 230-21 12GM, a medication used to treat asthma and chronic obstructive pulmonary disease (COPD). This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,581.98, is for the supply of Fluticasone-Salmeterol 115-21 12GM, a prescription medication used for the treatment of respiratory conditions. The contract has a firm fixed price and a completion date of January 16, 2025. This contract is not designated as a set-aside....
This is a $2,302.05 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of fluticasone-salmeterol 115-21 12GM, a medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of April 15, 2025 and is a firm fixed price contract. Amerisourcebergen holds a significant $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, with a ceiling value of $5,153.80 and a period of performance through March 6, 2025. The contract is a firm fixed price delivery order, with no set-aside designation, suggesting open competition. AmerisourceBergen holds...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product, with a ceiling value of $2,111.34 and a period of performance through April 4, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,069.85 and is for the delivery of fluticasone-salmeterol 115-21 12GM, a pharmaceutical product. The contract is a firm fixed price, delivery order contract with a period of performance ending on February 5, 2025. The contract is not set aside for any...
  • SPE2DB24D2216
    Indefinite Delivery Contract
  • SPE2DB24D2216-SPE2DB25FGNNB
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of fluticasone-salmeterol 45-21 12GM, a medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract has a firm fixed price and a ceiling value of $3,172.98, with a period of performance through May 2, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 7/31/25, 9:52 AM